Baiyaphytopharm

Baiya Phytopharm Co., Ltd. is a clinical-stage biopharmaceutical company based in Thailand, founded in 2018. The company's slogan, "THE FIRST PLANT-PRODUCED BIOLOGICS COMPANY IN SOUTH EAST ASIA REGION," reflects its unique focus on utilizing BaiyaPharmingTM protein for therapeutics and vaccines. The company's expertise lies in plant biotech, pharmaceutical production professions, and clinical development capabilities, allowing them to address unmet medical needs in the ASIA-Pacific region.

With a broad proprietary portfolio that includes monoclonal antibody for cancer or infectious disease and new vaccines for neglected tropical diseases, Baiya Phytopharm is dedicated to strengthening health security for all people. The company recently secured a THB45.00M Seed Round investment on January 1, 2023, with CU ENTERPRISE CO., LTD. as the investor. Baiya Phytopharm's innovative approach and focus on addressing critical medical challenges make it a compelling investment opportunity in the Biopharma, Manufacturing, and Pharmaceutical industries.